PH12020500095A1 - Improved dual specific polypeptide molecule - Google Patents
Improved dual specific polypeptide moleculeInfo
- Publication number
- PH12020500095A1 PH12020500095A1 PH12020500095A PH12020500095A PH12020500095A1 PH 12020500095 A1 PH12020500095 A1 PH 12020500095A1 PH 12020500095 A PH12020500095 A PH 12020500095A PH 12020500095 A PH12020500095 A PH 12020500095A PH 12020500095 A1 PH12020500095 A1 PH 12020500095A1
- Authority
- PH
- Philippines
- Prior art keywords
- polypeptide molecule
- specific polypeptide
- dual specific
- improved dual
- region derived
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding region derived from a T cell receptor (TCR) being specific for a major histocompatibility complex (MHC)-associated viral peptide epitope, and a binding region derived from an antibody capable of recruiting human immune effector cells by specifically binding to a surface antigen of said cells, as well as methods of making the bispecific polypeptide molecule, and uses thereof.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762532713P | 2017-07-14 | 2017-07-14 | |
DE102017115966.5A DE102017115966A1 (en) | 2017-07-14 | 2017-07-14 | Polypeptide molecule with improved dual specificity |
DE102017119866 | 2017-08-30 | ||
US201862658318P | 2018-04-16 | 2018-04-16 | |
DE102018108995 | 2018-04-16 | ||
PCT/EP2018/069157 WO2019012141A1 (en) | 2017-07-14 | 2018-07-13 | Improved dual specificity polypeptide molecule |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12020500095A1 true PH12020500095A1 (en) | 2020-12-07 |
Family
ID=70848164
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12020500095A PH12020500095A1 (en) | 2017-07-14 | 2020-01-14 | Improved dual specific polypeptide molecule |
PH12020500098A PH12020500098A1 (en) | 2017-07-14 | 2020-01-14 | Improved dual specific polypeptide molecule |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12020500098A PH12020500098A1 (en) | 2017-07-14 | 2020-01-14 | Improved dual specific polypeptide molecule |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2021019626A (en) |
CL (2) | CL2020000098A1 (en) |
HR (1) | HRP20210759T1 (en) |
IL (2) | IL272046A (en) |
PH (2) | PH12020500095A1 (en) |
ZA (1) | ZA202000636B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2968520T1 (en) * | 2013-03-14 | 2022-01-31 | Macrogenics, Inc. | Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor |
-
2020
- 2020-01-13 CL CL2020000098A patent/CL2020000098A1/en unknown
- 2020-01-13 CL CL2020000097A patent/CL2020000097A1/en unknown
- 2020-01-14 IL IL272046A patent/IL272046A/en unknown
- 2020-01-14 IL IL272045A patent/IL272045A/en unknown
- 2020-01-14 PH PH12020500095A patent/PH12020500095A1/en unknown
- 2020-01-14 PH PH12020500098A patent/PH12020500098A1/en unknown
- 2020-01-30 ZA ZA2020/00636A patent/ZA202000636B/en unknown
- 2020-10-23 JP JP2020177784A patent/JP2021019626A/en active Pending
-
2021
- 2021-05-12 HR HRP20210759TT patent/HRP20210759T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021019626A (en) | 2021-02-18 |
IL272045A (en) | 2020-03-31 |
ZA202000636B (en) | 2021-07-28 |
IL272046A (en) | 2020-03-31 |
CL2020000098A1 (en) | 2020-05-29 |
CL2020000097A1 (en) | 2020-05-29 |
HRP20210759T1 (en) | 2021-06-11 |
PH12020500098A1 (en) | 2020-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020011744A (en) | Improved dual specificity polypeptide molecule. | |
MX2020010241A (en) | Cellular immunotherapy compositions and uses thereof. | |
MX2023006482A (en) | Bispecific antibodies specific for a costimulatory tnf receptor. | |
AU2018258045A1 (en) | Chimeric antibody/T-cell receptor constructs and uses thereof | |
AU2018260863A1 (en) | Human IgG1 Fc region variants and uses thereof | |
WO2017147383A8 (en) | Modified cells for immunotherapy | |
MX2017015928A (en) | T cell receptor like antibodies having fine specificity. | |
MX2021011696A (en) | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123. | |
MX2022011659A (en) | Antigen binding proteins that bind pd-l1. | |
AU2018253589A1 (en) | Antibodies, pharmaceutical compositions and uses thereof | |
BR112017013981A2 (en) | anti-cll1-specific chimeric single-chain antigen receptors (sccars) for cancer immunotherapy | |
EA201992536A1 (en) | TCR AND PEPTIDES | |
MX2016005687A (en) | Methods for enhancing immunosuppressive therapy by multiple administration of alpha beta tcr-binding polypeptide. | |
WO2018187356A3 (en) | Protein antigens and uses thereof | |
AU2015287227A8 (en) | Immune-stimulating monoclonal antibodies against human interleukin-2 | |
WO2017124001A3 (en) | T cell receptor-like antibodies specific for foxp3-derived peptides | |
WO2018175585A3 (en) | Antigen discovery for t cell receptors isolated from patient tumors recognizing wild-type antigens and potent peptide mimotopes | |
AR112228A1 (en) | POLYPEPTIDE MOLECULE WITH ENHANCED DUAL SPECIFICITY | |
MX2022000379A (en) | Antibodies which bind to cancer cells and target radionuclides to said cells. | |
PH12020500095A1 (en) | Improved dual specific polypeptide molecule | |
EA202090250A1 (en) | IMPROVED DOUBLE SPECIFICITY POLYPEPTIDE MOLECULE | |
MA49561A (en) | DUAL SPECIFIC ENHANCED POLYPEPTIDIC MOLECULE | |
WO2021016534A3 (en) | Antigenic polypeptides and methods of use thereof | |
AR121809A2 (en) | PEPTIDE, EXPRESSION VECTOR, HOST CELL, ACTIVATED T-LYMPHOCYTE, ANTIBODY, T-CELL RECEPTOR, PHARMACEUTICAL COMPOSITION, KIT AND RELATED METHODS | |
AR121984A2 (en) | METHODS FOR PREPARING CELLS EXPRESSING RECEPTORS OF CHIMERIC ANTIGENS |